A Randomized Study of the Efficacy and Safety of OncoGel Treatment as an Adjunctive Therapy to Systemic Chemotherapy and Concurrent External Beam Radiation Prior to Surgery in Subjects With Localized or Loco-Regional Esophageal Cancer.

Status: Discontinued

Phase of Trial: Phase II

Latest Information Update: 19 May 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Paclitaxel (Primary) ; Cisplatin; Fluorouracil
Indications Oesophageal cancer
Focus Adverse reactions; Therapeutic Use

Most Recent Events

24 Nov 2016 Results published in the Gastrointestinal Endoscopy
10 May 2011 Results presented at Digestive Disease Week 2011.
05 Apr 2011 Status changed from active, no longer recruiting to discontinued.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com

Welcome to AdisInsight